ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NHS National Framework for Generics Orals, Non-Parenteral & Housekeeping

NHS England · Tender notice on Find a Tender

Tender information last checkedLast checked 21 Sept 2026, 14:38.

Opportunity overview

NHS National Framework for Generics Orals, Non-Parenteral & Housekeeping Offer Reference number: CM/PHG/25/5738 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/25/5738/01 - Oral & Non-Parenteral Products: CESW (Central/Midlands and Southwest): 1st June 2027 to 31st May 2030 (36 months) LSNE (London South and Northeast 1st June 2027 to 31st May 2030 (36 months) NWLN (Northwest and London North): 1st June 2027 to 31st May 2030 (36 months) CM/PHG/25/5738/02 – Hospital Only (Orals, Non-Parenteral & Housekeeping) Products: DCE (Central/Midlands) & DSW (Southwest): 1st June 2027 to 30th September 2029 (28 months) DLS (London South) & DNE (Northeast): 1st June 2027 to 31st May 2028 (12 months) DNW (Northwest) & DLN (London North): 1st June 2027 to 31st January 2029 (20 months)

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Lot 1 - CM/PHG/25/5738/01 Orals & Non-Parenteral Products:£281.8m
  • Lot 2 - CM/PHG/25/5738/02 Hospital Only (Orals, Non-Parenteral & Housekeeping)£150.5m

Documents and notices

  • Tender notice on Find a TenderOpen source ↗
  • biddingDocumentsOpen source ↗
  • Additional Offer Schedule for: DXA063 - NINTEDANIB CAPSULES 150MG (60) DXA074 - NINTEDANIB CAPSULES 100MG (60) DMJ037 - DALBAVANCIN POWDER FOR SOLUTION FOR INFUSION VIALS 500MG (1)Open source ↗

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
CM/PHG/25/5738
Status
active
Procurement Method
open
Procurement Method Details
Open procedure
Main Procurement Category
goods
Above Threshold
Yes
How to submit
The procurement documents are available for unrestricted and full direct access, free of charge at https://health-family.force.com/s/Welcome Additional information may be obtained from the abovementioned address. Tenders must be submitted to the abovementioned address.

Legal basis

Id
2023/54
Scheme
UKPGA

Covered By

GPA

Techniques

Has Framework Agreement
Yes

Framework Agreement

Method
withReopeningCompetition
Type
open
Buyer Categories
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points.
Description
Please refer to the ITO Documents for the Operation Description.

Buyer Location Restrictions

Entry 1

Gazetteer

Scheme
GB-ITL

Identifiers

UKC
Entry 2

Gazetteer

Scheme
GB-ITL

Identifiers

UKD
Entry 3

Gazetteer

Scheme
GB-ITL

Identifiers

UKE
Entry 4

Gazetteer

Scheme
GB-ITL

Identifiers

UKF
Entry 5

Gazetteer

Scheme
GB-ITL

Identifiers

UKG
Entry 6

Gazetteer

Scheme
GB-ITL

Identifiers

UKH
Entry 7

Gazetteer

Scheme
GB-ITL

Identifiers

UKI
Entry 8

Gazetteer

Scheme
GB-ITL

Identifiers

UKJ
Entry 9

Gazetteer

Scheme
GB-ITL

Identifiers

UKK

Submission terms

Electronic Submission Policy
allowed

Languages

en

Tender Period

Ends
19 Oct 2026, 13:00

Expected award period

Ends
4 Jan 2027, 23:59

Amendments

Entry 1
Description
Additional Offer Schedule added for: DXA063 - NINTEDANIB CAPSULES 150MG (60) DXA074 - NINTEDANIB CAPSULES 100MG (60) DMJ037 - DALBAVANCIN POWDER FOR SOLUTION FOR INFUSION VIALS 500MG (1)
Id
089063-2026

Lots and requirements

Entry 1
Id
1
Title
Lot 1 - CM/PHG/25/5738/01 Orals & Non-Parenteral Products:
Description
Potential periods of call-offs under the framework agreement: CESW (Central/Midlands and Southwest): 1st June 2027 to 31st May 2030 (36 months) LSNE (London South and Northeast 1st June 2027 to 31st May 2030 (36 months) NWLN (Northwest and London North): 1st June 2027 to 31st May 2030 (36 months)
Status
active
Has Renewal
Yes

Value

Including VAT
338,149,200
Amount
281,791,000
Currency
GBP

Award criteria

Weighting Description
Price is not the only award criterion and all criteria are stated only in the procurement documents.

Criteria

Criterion 1
Type
price
Name
Price is not the only award criterion

Suitability

Sme
Yes

Contract period

Starts
1 Jun 2027, 00:00
Ends
31 May 2030, 23:59
Max Extent Date
31 May 2031, 23:59

Renewal

Description
Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 12 months. Total maximum contract length of 48 months
Entry 2
Id
2
Title
Lot 2 - CM/PHG/25/5738/02 Hospital Only (Orals, Non-Parenteral & Housekeeping)
Description
Potential periods of call-offs under the framework agreement: DCE (Central/Midlands) & DSW (Southwest): 1st June 2027 to 30th September 2029 (28 months) DLS (London South) & DNE (Northeast): 1st June 2027 to 31st May 2028 (12 months) DNW (Northwest) & DLN (London North): 1st June 2027 to 31st January 2029 (20 months)
Status
active
Has Renewal
Yes

Value

Including VAT
180,590,510
Amount
150,492,092
Currency
GBP

Award criteria

Weighting Description
Price is not the only award criterion and all criteria are stated only in the procurement documents.

Criteria

Criterion 1
Type
price
Name
Price is not the only award criterion

Suitability

Sme
Yes

Contract period

Starts
1 Jun 2027, 00:00
Ends
30 Sept 2029, 23:59
Max Extent Date
31 May 2031, 23:59

Renewal

Description
Option or options to extend (at the authority’s discretion) with a total maximum contract length of 48 months

Items and delivery

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Item 2
Id
2
Related Lot
2

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products

Published documents

Entry 1
Id
A-22715
Document Type
biddingDocuments
Format
application/x-zip-compressed
Entry 2
Id
A-22716
Document Type
biddingDocuments
Description
Additional Offer Schedule for: DXA063 - NINTEDANIB CAPSULES 150MG (60) DXA074 - NINTEDANIB CAPSULES 100MG (60) DMJ037 - DALBAVANCIN POWDER FOR SOLUTION FOR INFUSION VIALS 500MG (1)
Format
application/vnd.ms-excel
Entry 3
Id
conflictOfInterest
Document Type
conflictOfInterest
Entry 4
Id
089063-2026
Document Type
tenderNotice
Notice Type
UK4
Description
Tender notice on Find a Tender
Published
21 Sept 2026, 11:46
Format
text/html

Buyer, suppliers and contacts

Organisation 1
Name
NHS England
Id
GB-PPON-PDPT-3135-BWWY

Identifier

Scheme
GB-PPON
Id
PDPT-3135-BWWY

Address

Street Address
Wellington House, 133-135 Waterloo Rd
Locality
London
Postal Code
SE1 8UG
Country
GB
Country Name
United Kingdom
Region
UKI45

Contact

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthorityCentralGovernment
Description
Public authority - central government

Recorded locations

  • Buyer location · London · UKI45 · SE1 8UG · United Kingdom

Notice and amendment history

3 published notice versions reviewed by ProcuraAxis.

3 VERSIONS
  1. 083843-2026Preliminary market engagement notice on Find a Tender ·
  2. 087775-2026Tender notice on Find a Tender ·
  3. 089063-2026Tender notice on Find a Tender ·